Development of phospholipid vesicle-based permeation assay models capable of evaluating percutaneous penetration enhancing effect

References

• Menon GK, Cleary GW, Lane ME. The structure and function of the stratum corneum. Int J Pharm. 2012;435:3–9.
   PubMed Web of Science ®Google Scholar
• Lane ME. Skin penetration enhancers. Int J Pharm. 2013;447:12–21.
   PubMed Web of Science ®Google Scholar
• Ibrahim SA, Li SK. Chemical enhancer solubility in human stratum corneum lipids and enhancer mechanism of action on stratum corenum lipid domain. Int J Pharm. 2010;383:89–98.
   PubMed Web of Science ®Google Scholar
• Jacobi U, Kaiser M, Toll R, et al. Porcine ear skin: an in vitro model for human skin. Skin Res Technol. 2007;13:19–24.
   PubMed Web of Science ®Google Scholar
• Flaten GE, Palac Z, Engesland A, et al. In vitro skin models as a tool in optimization of drug formulation. Eur J Pharm Sci. 2015;75:10–24.
   PubMed Web of Science ®Google Scholar
• Luo L, Patel A, Sinko B, et al. A comparative study of the in vitro permeation of ibuprofen in mammalian skin, the PAMPA model and silicone membrane. Int J Pharm. 2016;505:14–19.
   PubMed Web of Science ®Google Scholar
• Flaten GE, Dhanikula AB, Luthman K, et al. Drug permeability across a phospholipid vesicle based barrier: a novel approach for studying passive diffusion. Eur J Pharm Sci. 2006;27:80–90.
   PubMed Web of Science ®Google Scholar
• Engesland A, Škalko-Basnet n, Flaten GE. Phospholipid vesicle-based permeation assay and EpiSkin® in assessment of drug therapies destined for skin administration. J Pharm Sci. 2015;104:1119–1127.
   PubMed Web of Science ®Google Scholar
• Engesland A, Škalko-Basnet n, Flaten GE. In vitro models to estimate drug penetration through the compromised stratum corneum barrier. Drug Dev Ind Pharm. 2016;42:1742–1751.
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhu X, Shen J, et al. Characterization of a liposome-based artificial skin membrane for in vitro permeation studies using Franz diffusion cell device. J Liposome Res. 2016. Forthcoming. [cited 2016 Sept 28]. DOI:10.1080/08982104.2016.1231205.
   Web of Science ®Google Scholar
• Liu P, Duan J, Hua Y, et al. Effects of Xiang-Fu-Si-Wu Decoction and its main components for dysmenorrhea on uterus contraction. J Ethnopharmacol. 2011;133:591–597.
   PubMed Web of Science ®Google Scholar
• Pan Y, Li Z, Qian D, et al. Effects of different penetration enhancers on pharmacokinetics of active components in Xiangfu Siwu transdermal patches. Zhongguo Zhong Yao Za Zhi. 2016;41:294–302.
   PubMedGoogle Scholar
• Li ZH, Liu P, Qian DW, et al. In vitro transdermal delivery of the active fraction of xiangfusiwu decoction based on principal component analysis. Yao Xue Xue Bao. 2013;48:933–939.
   PubMedGoogle Scholar
• Chen J, Jiang QD, Chai YP, et al. Natural terpenes as penetration enhancers for transdermal drug delivery. Molecules. 2016;21:E1709.
   PubMed Web of Science ®Google Scholar
• Wang J, Dong C, Song Z, et al. Monocyclic monoterpenes as penetration enhancers of ligustrazine hydrochloride for dermal delivery. Pharm Dev Technol. 2017;22:571–577.
   PubMed Web of Science ®Google Scholar
• Parhi R, Suresh P, Mondal S, et al. Novel penetration enhancers for skin applications: a review. Curr Drug Deliv. 2012;9:219–230.
   PubMed Web of Science ®Google Scholar
• Shibata H, Yomota C, Okuda H. Simultaneous determination of polyethylene glycol-conjugated liposome components by using reversed-phase high-performance liquid chromatography with UV and evaporative light scattering detection. AAPS Pharm Sci Tech. 2013;14:811–817.
   PubMed Web of Science ®Google Scholar
• Kanzer J, Tho I, Flaten GE, et al. In-vitro permeability screening of melt extrudate formulations containing poorly water-soluble drug compounds using the phospholipid vesicle-based barrier. J Pharm Pharmacol. 2010;62:1591–1598.
   PubMed Web of Science ®Google Scholar
• Flaten GE, Skar ML, Luthman K, et al. Drug permeability across a phospholipid vesicle-based barrier: 3. Characterization of drug-membrane interactions and effect of agitation on the barrier integrity and on the permeability. Eur J Pharm Sci. 2007;30:324–332.
   PubMed Web of Science ®Google Scholar
• Liu Y, Chen JY, Shang HT, et al. Light microscopic, electron microscopic, and immunohistochemical comparison of Bama minipig (Sus scrofa domestica) and human skin. Comp Med. 2010;60:142–148.
   PubMed Web of Science ®Google Scholar
• Chen J, Jiang QD, Wu YM, et al. Potential of essential oils as penetration enhancers for transdermal administration of ibuprofen to treat dysmenorrhoea. Molecules. 2015;20:18219–18236.
   PubMed Web of Science ®Google Scholar
• Fischer SM, Flaten GE, Hagesaether E, et al. In-vitro permeability of poorly water soluble drugs in the phospholipid vesicle-based permeation assay: the influence of nonionic surfactants. J Pharm Pharmacol. 2011;63:1022–1030.
   PubMed Web of Science ®Google Scholar
• Sammeta SM, Repka MA, Narasimha Murthy S. Magnetophoresis in combination with chemical enhancers for transdermal drug delivery. Drug Dev Ind Pharm. 2011;37:1076–1082.
   PubMed Web of Science ®Google Scholar
• Davies DJ, Ward RJ, Hdylings JR. Multi-species assessment of electrical resistance as a skin integrity marker for in vitro percutaneous absorption studies. Toxicol in Vitro. 2004;18:351–358.
   PubMed Web of Science ®Google Scholar
• Ravichandran S, Mortensen LJ, Delouise LA. Quantification of human skin barrier function and susceptibility to quantum dot skin penetration. Nanotoxicology. 2011;5:678–686.
   Web of Science ®Google Scholar
• Rachakonda VK, Yerramsetty KM, Madihally SV, et al. Screening of chemical penetration enhancers for transdermal drug delivery using electrical resistance of skin. Pharm Res. 2008;25:2697–2704.
   PubMed Web of Science ®Google Scholar
• Groen E, Poole DS, Gooris GS, et al. Investigating the barrier function of skin lipid models with varying compositions. Eur J Pharm Biopharm. 2011;79:334–342.
   PubMed Web of Science ®Google Scholar
• Flaten GE, Bunjes H, Luthman K, et al. Drug permeability across a phospholipid vesicle-based barrier 2. Characterization of barrier structure, storage stability and stability towards pH changes. Eur J Pharm Sci. 2006;28:336–343.
   PubMed Web of Science ®Google Scholar
• Bartosova L, Bajgar J. Transdermal drug delivery in vitro using diffusion cells. Curr Med Chem. 2012;19:4671–4677.
   PubMed Web of Science ®Google Scholar
• Laugel C, Yagoubi N, Baillet A. ATR-FTIR spectroscopy: a chemometric approach for studying the lipid organisation of the stratum corneum. Chem Phys Lipids. 2005;135:55–68.
   PubMed Web of Science ®Google Scholar
• Lan Y, Wang J, Li H, et al. Effect of menthone and related compounds on skin permeation of drugs with different lipophilicity and molecular organization of stratum corneum lipids. Pharm Dev Technol. 2016;21:389–398.
   PubMed Web of Science ®Google Scholar